Innate and adaptive immunity in female genital tract: Cellular responses and interactions

Immunological Reviews

Volumn 206, Issue , 2005, Pages 306-335

  Wira, Charles R ^a   Fahey, John V ^a   Sentman, Charles L ^a   Pioli, Patricia A ^a   Shen, Li ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; SEX HORMONE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; BACTERIAL TRANSMISSION; BONE MARROW CELL; CELL ACTIVITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; EPITHELIUM CELL; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MENSTRUAL CYCLE; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPRODUCTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; SPERMATOZOON; UTERINE CERVIX; UTERINE TUBE; UTERUS; VAGINA; VIRUS TRANSMISSION;

ANIMALS; FEMALE; GENITALIA, FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL;

EID: 23344453110     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00287.x     Document Type: Review

References (360)

1. Wira CR, Fahey JV, White HD, Yeaman GR, Given AL, Howell AL. The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In: Glasser S, Aplin J, Guidice L, Tabibzadeh S, eds. The Endometrium. New York: Taylor & Francis, 2002:371-404.
2. Wira CR, Crane-Godreau MA, Grant-Tschudy KS. Role of sex hormones and cytokines in regulating the mucosal immune system in the female reproductive tract. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology. New York: Academic Press, 2005:1661-1676.
3. Kutteh WH, Mestecky J, Wira CR. Mucosal immunity in the human female reproductive tract. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal Immunology. New York: Academic Press, 2005:1631-1646.
4. Janeway CAJ. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54:1-13.
5. Janeway CAJ, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
6. Medzhitov RM, Janeway CJ. Innate immunity. N Engl J Med 2000;343:338-344.
7. Ganz T. Defensins and host defense. Science 1999;286:420-421.
8. Schutte BC, McCray PB Jr. beta-defensins in lung host defense. Ann Rev Physiol 2002;64:709-748.
9. McNeely T, Dealy M, Dripps D, Orenstein J, Eisenberg S, Wahl S. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995;96:456-464.
10. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
11. Yang D, et al. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-528.
12. Grossman CJ. Interactions between the gonadal steroids and the immune system. Science 1985;227:257-261.
13. Wira CR, Richardson J, Prabhala R. Endocrine regulation of mucosal immunity: effect of sex hormones and cytokines on the afferent and efferent arms of the immune system in the female reproductive tract. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of Mucosal Immunology. New York: Academic Press, 1994:705-718.
14. Muir A, et al. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Resp Cell Mol Biol 2004;30:777-783.
15. Cario E, Brown D, McKee M, Lynch-Devaney K, Gerken G, Podolsky DK. Commensal-associated molecular patterns induce selective Toll-like receptor-traffing from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Path 2002;165:160-173.
16. Cates W. Priorities for sexually transmitted diseases in the late 1980s and beyond. Sex Trans Dis 1986;13:114-117.
17. World Health Organization (WHO). AIDS Epidemic Update 2004.
18. Peterman TA, Curran JW. Sexual transmission of human immunodeficiency virus. JAMA 1986;256:2222-2226.
19. Calabrese LH, Gopalakrishna KV. Transmission of HTLV-III infection from man to woman to man. N Eng J Med 1986;314:987.
20. Hocini H, Becquart P, Bouhlal H, Adle-Biassette H, Kazatchkine M, Belec L. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin Diagn Lab Immunol 2000;7:515-518.
21. Chang TL, Vargas J Jr, DelPortillo A, Klotman ME. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest 2005:1-9.
22. Wira CR, Grant-Tschudy KS, Crane-Godreau M. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. AJRI 2005;53:1-12.
23. Fahey JV, Schaefer TM, Channon JY, Wira CR. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Human Reproduction 2005;20:1439-1446.
24. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004;112:428-436.
25. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly (I:C). J Immunol 2005;174:992-1002.
26. Young SL, Lyddon TD, Jorgenson RL, Misfeldt ML. Expression of Toll-like receptors in human endometrial epithelial cells and cell lines. Am J Reprod Immunol 2004;52:67-73.
27. Wira CR, Fahey JV, White HD, Yeaman GR, Givan AL, Howell AL. The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In: Glasser S, Aplin J, Giudice L, Tabibzadeh S, eds. The Endometrium. London: Taylor & Francis 2002:371-404.
28. Cooke PS, et al. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci USA 1997;94:6535-6540.
29. Wira CR, Stern J. Endocrine regulation of the mucosal immune system in the female reproductive tract: control of IgA, IgG, and secretory component during the reproductive cycle, at implantation and throughout pregnancy. In: Pasqualini JR, Scholler R, eds. Hormones and Fetal Pathophysiology. New York: Marcel Dekker, Inc., 1992:343-368.
30. Hershberg RM. The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2002;283:G833-G839.
31. Grant KS, Wira CR. Effect of mouse uterine stromal cells on epithelial cell transepithelial resistance (TER) and TNFalpha and TGFbeta release in culture. Biol Reprod 2003;69:1091-1098.
32. Grant-Tschudy KS, Wira CR. Effect of estradiol on mouse uterine epithelial cell transepithelial resistance (TER). Am J Reprod Immunol 2004;52:252-262.
33. Imagawa W, Pedchenko VK, Helber J, Zhang H. Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 2002;80:213-230.
34. Zhang HZ, Bennett JM, Smith KT, Sunil N, Haslam SZ. Estrogen mediates mammary epithelial cell proliferation in serum-free culture indirectly via mammary strom-derived hepatocyte growth factor. Endocrinology 2002;143:3427-3434.
35. Grant-Tschudy KS, Wira CR. Hepatocyte growth factor regulation of uterine epithelial cell transepithelial resistance (TER) and TNF alpha release in culture. Biol Reprod 2005;72:814-821.
36. Darville T, O'Neill JM, Andrews CWJ, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003;171:6187-6197.
37. Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, Guyre PM. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004;72:5799-5806.
38. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 2002;168:2424-2432.
39. Kayisli UA, Mahutte NG, Arici A. Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002;47:213-221.
40. Hirata T, et al. Evidence for the presence of toll-like receptor 4 system in the human endometrium. J Clin Endocrinol Metab 2005;90:548-556.
41. Backhed F, Meijer L, Normark S, Richter-Dahlfors A. TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell Microbiol 2002;4:493-501.
42. Ganz T, Lehrer RI. Defensins. Pharmacol Ther 1995;66:191-205.
43. Quayle AJ, et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998;152:1247-1258.
44. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T. Human β-defensin-1, an antimicrobial peptide of urogenital tissues. J Clin Invest 1998;101:1633-1642.
45. King AE, Fleming DC, Critchley HO, Kelly RW. Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol Hum Reprod 2002;8:341-349.
46. King AE, Fleming DC, Critchley HO, Kelly RW. Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol 2003;59:1-16.
47. Fahey JV, Wira CR. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002;185:1606-1613.
48. Denison FC, Kelly RW, Calder AA, Riley SC. Secretory leukocyte protease inhibitor concentration increases in amniotic fluid with the onset of labour in women: characterization of sites of release within the uterus. J Endocrinol 1999;161:299-306.
49. King AE, Morgan K, Sallenave JM, Kelly RW. Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone. Biochem Biophys Res Commun 2003;310:594-599.
50. King AE, Critchley HO, Kelly RW. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol Hum Reprod 2000;6:191-196.
51. Fleming DC, King AE, Williams AR, Critchley HO, Kelly RW. Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium. Fertil Steril 2003;79:856-863.
52. Chen D, Xu X, Cheon YP, Bagchi MK, Bagchi IC. Estrogen induces expression of secretory leukocyte protease inhibitor in rat uterus. Biol Reprod 2004;71:508-514.
53. Ace CI, Okulicz WC. Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol 2004;2:54.
54. Zhang D, Simmen RC, Michel FJ, Zhao G, Vale-Cruz D, Simmen FA. Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J Biol Chem 2002;277:29999-30009.
55. Quayle AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol 2002;57:61-79.
56. Tabibzadeh S. Evidence of T-cell activation and potential cytokine action in human endometrium. J Clin Endocrinol Metab 1990;71:645-649.
57. Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol Hum Reprod 1996;2:77-92.
58. Dominguez F, Pellicer A, Simon C. Paracrine dialogue in implantation. Mol Cell Endocrinol 2002;186:175-181.
59. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate immunity in the human female reproductive tract: Antiviral response of uterine epithelial cells to the TLR3 agonist poly (I:C). J Immunol 2005;174:992-1002.
60. Yang D, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-528.
61. Niyonsaba F, Ogawa H, Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 2004;111:273-281.
62. Crane-Godreau CA, Wira CR. MIP3alpha production by polarized uterine epithelial cells: response to apical treatment with Pam3Cys and LPS. Infect Immunol 2004;73:476-484.
63. Crane-Godreau MA, Wira CR. CCL20/macrophage inflammatory protein 3alpha and tumor necrosis factor alpha production by primary uterine epithelial cells in response to treatment with lipopolysaccharide or Pam3Cys. Infect Immun 2005;73:476-484.
64. Hoover DM, et al. The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem 2002;277:37647-37654.
65. Critchley HO, Kelly RW, Brenner RM, Baird DT. The endocrinology of menstruation - a role for the immune system. Clin Endocrinol (Oxf) 2001;55:701-710.
66. Givan AL, et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of Fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997;38:350-359.
67. Yeaman GR, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 1997;61:427-435.
68. Rescigno M, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361-367.
69. Jacobsson B, Holst RM, Wennerholm UB, Andersson B, Lilja H, Hagberg H. Monocyte chemotactic protein-1 in cervical and amniotic fluid: relationship to microbial invasion of the amniotic cavity, intra-amniotic inflammation, and preterm delivery. Am J Obstet Gynecol 2003;189:1161-1167.
70. Matsuda Y, Kouno S, Nakano H. Effects of antibiotic treatment on the concentrations of interleukin-6 and interleukin-8 in cervicovaginal fluid. Fetal Diagn Ther 2002;17:228-232.
71. Goepfert AR, et al. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. Am J Obstet Gynecol 2001;184:483-488.
72. Tanaka Y, Narahara H, Takai N, Yoshimatsu J, Anai T, Miyakawa I. Interleukin-1beta and interleukin-8 in cervicovaginal fluid during pregnancy. Am J Obstet Gynecol 1998;179:644-649.
73. Simhan HN, Caritis SN, Krohn MA, Martinez de Tejada B, Landers DV, Hillier SL. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol 2003;189:560-567.
74. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004;190:1509-1519.
75. Baggiolini M. Activation and recruitment of neutrophil leukocytes. Clin Exp Immunol 1995;101:5-6.
76. Yoshimura T, Leonard EJ. Human monocyte chemoattractant protein-1: structure and function. Cytokines 1992;4:131-152.
77. Shen L, Fahey JV, Hussey SB, Asin SN, Wira CR, Fanger MW. Synergy between IL-8 and GM-CSF in reproductive tract epithelial cell secretions promotes enhanced neutrophil chemotaxis. Cell Immunol 2004;230:23-32.
78. Meter RA, Fahey JV, Wira CW. Secretion of monocyte chemotactic protein (MCP)-1 by polarized human uterine epithelium directs monocyte migration in culture. Fertil Steril 2005 (in press).
79. Gomez-Cambronero J, Horn J, Paul CC, Baumann MA. Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70, S6 kinase signaling pathway. J Immunol 2003;171:6846-6855.
80. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002;13:455-481.
81. Vaday GG, et al. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leukoc Biol 2001;69:885-892.
82. Wira CR, Sandoe CP. Origin of IgA and IgG antibodies in the female reproductive tract: regulation of the genital response by estradiol. Adv Exp Med Biol 1987;216A:403-412.
83. Richardson J, Kaushic C, Wira CR. Estradiol regulation of secretory component: expression by rat uterine epithelial cells. J Steroid Biochem Mol Biol 1993;47:143-149.
84. Menge AC, Mestecky J. Surface expression of secretory component and HLA class II DR antigen on glandular epithelial cells from human endometrium and two endometrial adenocarcinoma cell lines. J Clin Immunol 1993;13:259-264.
85. Sullivan DA, Underdown BJ, Wira CR. Steroid hormone regulation of free secretory component in the rat uterus. Immunology 1983;49:379-386.
86. Wira CR, Stern JE, Colby E. Estradiol regulation of secretory component in the uterus of the rat: evidence for involvement of RNA synthesis. J Immunol 1984;133:2624-2628.
87. Richardson JM, Kaushic C, Wira CR. Polymeric immunoglobulin (Ig) receptor production and IgA transcytosis in polarized primary cultures of mature rat uterine epithelial cells. Biol Reprod 1995;53:488-498.
88. Fahey JV, Humphrey SL, Stern JE, Wira CW. Secretory component production by polarized epithelial cells from the human female reproductive tract. Immunol Invest 1998;27:167-180.
89. Kaushic C, Frauendorf E, Wira CR. Polymeric immunoglobulin A receptor in the rodent female reproductive tract: expression in vagina and tissue specific mRNA regulation by sex hormones. Biol Reprod 1997;57:958-966.
90. Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol Today 2000;21:123-128.
91. Fahey JV, Prabhala RH, Guyre PM, Wira CR. Antigen-presenting cells in the human female reproductive tract: analysis of antigen presentation in pre- and post-menopausal women. Am J Reprod Immunol 1999;42:49-57.
92. Wallace PK, Yeaman GR, Johnson K, Collins JE, Guyre PM, Wira CR. MHC class II expression and antigen presentation by human endometrial cells. J Steroid Biochem Mol Biol 2001;76:203-211.
93. Wira CR, Rossoll RM. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 1995;84:505-508.
94. Wira CR, Rossoll RM. Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 1995;136:4526-4534.
95. Prabhala RH, Wira CR. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J Immunol 1995;155:5566-5573.
96. Wira CR, Roche MA, Rossoll RM. Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation. Endocrinology 2002;143:2872-2879.
97. Wira CR, Rossoll RM. Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen-presenting cell function. Immunology 2003;109:398-406.
98. Flaskerud JH, Ungvarski PJ. Overview and update of HIV disease. In: Ungvarski PJ, Flaskerud JH, eds. HIV/AIDS. A Guide to Primary Care Management. Philadelphia: W B Saunders Co, 1999:1-6.
99. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu Rev Immunol 1999;17:657-700.
100. Murdoch C, Monk PN, Finn A. Functional expression of chemokine receptor CXCR4 on human epithelial cells. Immunology 1999;98:36-41.
101. Howell AL, et al. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J Virol 1997;71:3498-3506.
102. Yeaman GR, et al. Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 2003;109:137-146.
103. Stein-Streilein J, Sonoda KH, Faunce D, Zhang-Hoover J. Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J Leukoc Biol 2000;67:488-494.
104. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol 1984;2:283-318.
105. Ashcroft GS, et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest 2003;111:1309-1318.
106. Carruba G, et al. Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J Cell Biochem 2003;90:187-196.
107. Phiel KL, Henderson RA, Adelman SJ, Elloso MM. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 2005;97:107-113.
108. Vegeto E, Pollio G, Pellicciari C, Maggi A. Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis. FASEB J 1999;13:793-803.
109. Mor G, et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 2003;170:114-122.
110. Maybin JA, Duncan WC. The human corpus luteum: which cells have progesterone receptors? Reproduction 2004;128:423-431.
111. King A, Gardner L, Loke YW. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum Reprod 1996;11:1079-1082.
112. Werb Z, Foley R, Munck A. Glucocorticoid receptors and glucocorticoid-sensitive secretion of neutral proteinases in a macrophage line. J Immunol 1978;121:115-121.
113. Werb Z, Foley R, Munck A. Interaction of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages. J Exp Med 1978;147:1684-1694.
114. Guo Z, Krucken J, Benten WP, Wunderlich F. Estradiol-induced nongenomic calcium signaling regulates genotropic signaling in macrophages. J Biol Chem 2002;277:7044-7050.
115. Givan AL, et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997;38:350-359.
116. Hunt JS. Immunologically relevant cells in the uterus. Biol Reprod 1994;50:461-466.
117. DeLoia JA, Stewart-Akers AM, Brekosky J, Kubik CJ. Effects of exogenous estrogen on uterine leukocyte recruitment. Fertil Steril 2002;77:548-554.
118. Jones RL, Kelly RW, Critchley HO. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod 1997;12:1300-1306.
119. Kamat BR, Isaacson PG. The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am J Pathol 1987;127:66-73.
120. Arici A, Senturk LM, Seli E, Bahtiyar MO, Kim G. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol Reprod 1999;61:85-90.
121. Jones RL, Hannan NJ, Kaitu'u TJ, Zhang J, Salamonsen LA. Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab 2004;89:6155-6167.
122. Akoum A, Jolicoeur C, Boucher A. Estradiol amplifies interleukin-1- induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. J Clin Endocrinol Metab 2000;85:896-904.
123. Wu R, Van der Hoek KH, Ryan NK, Norman RJ, Robker RL. Macrophage contributions to ovarian function. Hum Reprod Update 2004;10:119-133.
124. Merogi AJ, Marrogi AJ, Ramesh R, Robinson WR, Fermin CD, Freeman SM. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol 1997;28:321-331.
125. Erroi A, Sironi M, Chiaffarino F, Chen ZG, Mengozzi M, Mantovani A. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int J Cancer 1989;44:795-801.
126. Vegeto E, et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001;21:1809-1818.
127. Lambert KC, Curran EM, Judy BM, Lubahn DB, Estes DM. Estrogen receptor-alpha deficiency promotes increased TNF-alpha secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro. J Leukoc Biol 2004;75:1166-1172.
128. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791-800.
129. Roger T, Glauser MP, Calandra T. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria. J Endotoxin Res 2001;7:456-460.
130. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
131. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-752.
132. Macatonia SE, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995;154:5071-5079.
133. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
134. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
135. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996;93:2588-2592.
136. Komi J, Lassila O. Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 2000;95:2875-2882.
137. Paharkova-Vatchkova V, Maldonado R, Kovats S. Estrogen preferentially promotes the differentiation of CD11c+ CD11b (intermediate) dendritic cells from bone marrow precursors. J Immunol 2004;172:1426-1436.
138. Bengtsson AK, Ryan EJ, Giordano D, Magaletti DM, Clark EA. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 2004;104:1404-1410.
139. Driggers PH, Segars JH. Estrogen action and cytoplasmic signaling pathways. Part II. the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 2002;13:422-427.
140. Kammerer U, et al. Human decidua contains potent immunostimulatory CD83 (+) dendritic cells. Am J Pathol 2000;157:159-169.
141. Cameron P, Pope M, Granelli-Piperno A, Steinman RM. Dendritic cells and the replication of HIV-1. J Leukoc Biol 1996;59:158-171.
142. Grouard G, Clark EA. Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis. Curr Opin Immunol 1997;9:563-567.
143. Geijtenbeek TB, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587-597.
144. Jameson B, et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 2002;76:1866-1875.
145. Nagai Y, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002;3:667-672.
146. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000;164:558-561.
147. Dentener MA, Bazil V, Von Asmuth EJ, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993;150:2885-2891.
148. Liebler JM, Kunkel SL, Burdick MD, Standiford TJ, Rolfe MW, Strieter RM. Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemagglutinin and lipopolysaccharide. J Immunol 1994;152:241-249.
149. Freund A, et al. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 2004;23:6105-6114.
150. Arici A, Seli E, Zeyneloglu HB, Senturk LM, Oral E, Olive DL. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J Clin Endocrinol Metab 1998;83:1201-1205.
151. Wells TN, et al. Selectivity and antagonism of chemokine receptors. J Leukoc Biol 1996;59:53-60.
152. Merkel SM, Alexander S, Zufall E, Oliver JD, Huet-Hudson YM. Essential role for estrogen in protection against Vibrio vulnificus-induced endotoxic shock. Infect Immun 2001;69:6119-6122.
153. Medzhitov R, et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998;2:253-258.
154. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A. The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 1998;187:2097-2101.
155. Ruh MF, Bi Y, D'Alonzo R, Bellone CJ. Effect of estrogens on IL-1beta promoter activity. J Steroid Biochem Mol Biol 1998;66:203-210.
156. Jones BW, et al. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 2001;69:1036-1044.
157. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-1652.
158. Tsutsumi-Ishii Y, Nagaoka I. Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 2003;170:4226-4236.
159. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
160. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001;13:458-464.
161. Ferlazzo G, et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003;33:306-313.
162. Bellone G, Valiante NM, Viale O, Ciccone E, Moretta L, Trinchieri G. Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones. J Exp Med 1993;177:1117-1125.
163. Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:1840-1845.
164. Glas R, Franksson L, Une C, Eloranta ML, Ohlen C, Orn A, Karre K. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J Exp Med 2000;191:129-138.
165. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens 2004;63:1-12.
166. Rebmann V, Regel J, Stolke D, Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003;13:371-377.
167. Ma D, Gu MJ, Liu BQ. A preliminary study on natural killer activity in patients with gynecologic malignancies. J Tongji Med Univ 1990;10:159-163.
168. Yang JH, Chen MJ, Chen HF, Lee TH, Ho HN, Yang YS. Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum Reprod 2004;19:1974-1978.
169. Maeda N, Izumiya C, Yamamoto Y, Oguri H, Kusume T, Fukaya T. Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril 2002;77:297-302.
170. Thum MY, et al. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod 2004;19:2395-2400.
171. Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine immunologic perspectives. Endocr Rev 2004;26:44-62.
172. Hiby SE, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004;200:957-965.
173. Sakai M, et al. Serum granulysin is a marker for Th1 type immunity in pre-eclampsia. Clin Exp Immunol 2004;136:114-119.
174. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656-663.
175. Jacobs R, et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001;31:3121-3127.
176. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-640.
177. Jonges LE, et al. The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood. Scand J Immunol 2001;53:103-110.
178. Fehniger TA, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003;101:3052-3057.
179. Ferlazzo G, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc
180. Moretta A, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223.
181. King A, Wellings V, Gardner L, Loke YW. Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum Immunol 1989;24:195-205.
182. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod 1991;6:791-798.
183. King A, Hiby SE, Verma S, Burrows T, Gardner L, Loke YW. Uterine NK cells and trophoblast HLA class I molecules. Am J Reprod Immunol 1997;37:459-462.
184. Eriksson M, Meadows SK, Wira CR, Sentman CL. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol 2004;76:667-675.
185. Ho HN, Chao KH, Chen CK, Yang YS, Huang SC. Activation status of T and NK cells in the endometrium throughout menstrual cycle and normal and abnormal early pregnancy. Hum Immunol 1996;49:130-136.
186. Verma S, King A, Loke YW. Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur J Immunol 1997;27:979-983.
187. Koopman LA, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003;198:1201-1212.
188. Ferguson MM, McDonald FG. Oestrogen as an inhibitor of human NK cell cytolysis. FEBS Lett 1985;191:145-148.
189. Hou J, Zheng WF. Effect of sex hormones on NK and ADCC activity of mice. Int J Immunopharmacol 1988;10:15-22.
190. Screpanti I, Santoni A, Gulino A, Herberman RB, Frati L. Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes. Cell Immunol 1987;106:191-202.
191. Baral E, Nagy E, Berczi I. Modulation of lymphokine-activated killer cell-mediated cytotoxicity by estradiol and tamoxifen. Int J Cancer 1996;66:214-218.
192. Sulke AN, Jones DB, Wood PJ. Hormonal modulation of human natural killer cell activity in vitro. J Reprod Immunol 1985;7:105-110.
193. Yovel G, Shakhar K, Ben-Eliyahu S. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol 2001;81:254-262.
194. Thyss A, Caldani C, Bourcier C, Benita G, Schneider M. Comparison of natural killer activity during the first and second halves of the menstrual cycle in women. Br J Cancer 1984;50:127-128.
195. Henderson TA, Saunders PT, Moffett-King A, Groome NP, Critchley HO. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 2003;88:440-449.
196. King A. Uterine leukocytes and decidualization. Hum Reprod Update 2000;6:28-36.
197. White HD, et al. CD3+CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol 1997;158:3017-3027.
198. McKenzie J, King A, Hare J, Fulford T, Wilson B, Stanley M. Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease. J Pathol 1991;165:75-80.
199. Tabibzadeh S. Proliferative activity of lymphoid cells in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab 1990;70:437-443.
200. Wira CR, Fahey JV, White HD, Yeaman GR, Givan AL, Howell AL. The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In: Glasser S, Aplin J, Giudice L, Tabibzadeh S, eds. Endometrium. UK: Harwood Academic Publishers, 2002:371-404.
201. King A, Balendran N, Wooding P, Carter NP, Loke YW. CD3-leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Dev Immunol 1991;1:169-190.
202. Kammerer U, Marzusch K, Krober S, Ruck P, Handgretinger R, Dietl J. A subset of CD56+ large granular lymphocytes in first-trimester human decidua are proliferating cells. Fertil Steril 1999;71:74-79.
203. Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 1998;187:217-223.
204. Campbell JJ, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001;166:6477-6482.
205. Inngjerdingen M, Damaj B, Maghazachi AA. Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001;97:367-375.
206. Sentman CL, Meadows SK, Wira CR, Eriksson M. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol 2004;173:6760-6766.
207. Kitaya K, Nakayama T, Okubo T, Kuroboshi H, Fushiki S, Honjo H. Expression of macrophage inflammatory protein-1 beta in human endometrium: its role in endometrial recruitment of natural killer cells. J Clin Endocrinol Metab 2003;88:1809-1814.
208. Kitaya K, Nakayama T, Daikoku N, Fushiki S, Honjo H. Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium. J Clin Endocrinol Metab 2004;89:2470-2476.
209. Hanna J, et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. Blood 2003;102:1569-1577.
210. Drake PM, et al. Human placental cytotrophoblasts attract monocytes and CD56 (bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha. J Exp Med 2001;193:1199-1212.
211. Akiyama M, Okabe H, Takakura K, Fujiyama Y, Noda Y. Expression of macrophage inflammatory protein-1 alpha (MIP-1alpha) in human endometrium throughout the menstrual cycle. Br J Obstet Gynaecol 1999;106:725-730.
212. Red-Horse K, Drake PM, Gunn MD, Fisher SJ. Chemokine ligand and receptor expression in the pregnant uterus: reciprocal patterns in complementary cell subsets suggest functional roles. Am J Pathol 2001;159:2199-2213.
213. Chantakru S, Kuziel WA, Maeda N, Croy BA. A study on the density and distribution of uterine Natural Killer cells at mid pregnancy in mice genetically-ablated for CCR2, CCR 5 and the CCR5 receptor ligand, MIP-1 alpha. J Reprod Immunol 2001;49:33-47.
214. Rot A, Von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004;22:891-928.
215. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol 1999;72:209-253.
216. Burrows TD, King A, Loke YW. Expression of adhesion molecules by human decidual large granular lymphocytes. Cell Immunol 1993;147:81-94.
217. Kruse A, Merchant MJ, Hallmann R, Butcher EC. Evidence of specialized leukocyte-vascular homing interactions at the maternal/fetal interface. Eur J Immunol 1999;29:1116-1126.
218. Frey M, et al. Differential expression and function of 1-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 1998;161:400-408.
219. Chantakru S, et al. Coordinate regulation of lymphocyte-endothelial interactions by pregnancy-associated hormones. J Immunol 2003;171:4011-4019.
220. van den Heuvel M, et al. Functional adhesion of CD56 cells to decidual endothelium predicts pregnancy success in in vitro fertilization. 12th International Congress of Immunology and 4th Annual Conference of FOCIS; 2004; Montreal: Canada. 140C.
221. Marzusch K, et al. Distribution of cell adhesion molecules on CD56++, CD3-, CD16-large granular lymphocytes and endothelial cells in first-trimester human decidua. Hum Reprod 1993;8:1203-1208.
222. Jokhi PP, King A, Sharkey AM, Smith SK, Loke YW. Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol 1994;153:4427-4435.
223. Rieger L, Kammerer U, Hofmann J, Sutterlin M, Dietl J. Choriocarcinoma cells modulate the cytokine production of decidual large granular lymphocytes in coculture. Am J Reprod Immunol 2001;46:137-143.
224. Jokhi PP, King A, Loke YW. Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine 1997;9:126-137.
225. Lidstrom C, Matthiesen L, Berg G, Sharma S, Ernerudh J, Ekerfelt C. Cytokine secretion patterns of NK cells and macrophages in early human pregnancy decidua and blood: implications for suppressor macrophages in decidua. Am J Reprod Immunol 2003;50:444-452.
226. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998;161:5821-5824.
227. Li XF, et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 2001;86:1823-1834.
228. Stewart CL, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992;359:76-79.
229. Nieto M, et al. Roles of chemokines and receptor polarization in NK-target cell interactions. J Immunol 1998;161:3330-3339.
230. Taub DD, Sayers TJ, Carter CR, Ortaldo JR. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995;155:3877-3888.
231. Hedrick JA, et al. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol 1997;158:1533-1540.
232. Robertson MJ, Williams BT, Christopherson K II, Brahmi Z, Hromas R. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Cell Immunol 2000;199:8-14.
233. Kelly RW, King AE, Critchley HO. Cytokine control in human endometrium. Reproduction 2001;121:3-19.
234. Chaouat G, et al. A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002;53:241-256.
235. Fehniger TA, et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999;162:4511-4520.
236. Kitaya K, Yasuda J, Yagi I, Tada Y, Fushiki S, Honjo H. IL-15 expression at human endometrium and decidua. Biol Reprod 2000;63:683-687.
237. Golander A, Barrett JR, Tyrey L, Fletcher WH, Handwerger S. Differential synthesis of human placental lactogen and human chorionic gonadotropin in vitro. Endocrinology 1978;102:597-605.
238. Maslar IA, Riddick DH. Prolactin production by human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 1979;135:751-754.
239. Gubbay O, Critchley HO, Bowen JM, King A, Jabbour HN. Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium. J Clin Endocrinol Metab 2002;87:2329-2335.
240. Chambers WH, Amoscato AA, Smith MS, Kenniston TW, Herberman RB, Appasamy PM. Prolactin receptor expression by rat NK cells. Nat Immun 1995;14:145-156.
241. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999;17:19-49.
242. Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, Di Santo JP. Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 2001;31:1900-1909.
243. Ye W, Zheng LM, Young JD, Liu CC. The involvement of interleukin (IL)-15 in regulating the differentiation of granulated metrial gland cells in mouse pregnant uterus. J Exp Med 1996;184:2405-2410.
244. Okada S, Okada H, Sanezumi M, Nakajima T, Yasuda K, Kanzaki H. Expression of interleukin-15 in human endometrium and decidua. Mol Hum Reprod 2000;6:75-80.
245. Barber EM, Pollard JW. The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection. J Immunol 2003;171:37-46.
246. Dunn CL, Critchley HO, Kelly RW. IL-15 regulation in human endometrial stromal cells. J Clin Endocrinol Metab 2002;87:1898-1901.
247. Chegini N, Ma C, Roberts M, Williams RS, Ripps BA. Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. J Reprod Immunol 2002;56:93-110.
248. Peel S. Granulated metrial gland cells. Adv Anat Embryol Cell Biol 1989;115:1-112.
249. Allavena P, Giardina G, Bianchi G, Mantovani A. IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. J Leukoc Biol 1997;61:729-735.
250. Castriconi R, et al. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci USA 2003;100:4120-4125.
251. Hayashi H, Inoue Y, Tsutsui H, Okamura H, Nakanishi K, Onozaki K. TGFbeta down-regulates IFN-gamma production in IL-18 treated NK cell line LNK5E6. Biochem Biophys Res Commun 2003;300:980-985.
252. Seo N, Tokura Y, Takigawa M, Egawa K. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J Immunol 1999;163:242-249.
253. Naganuma H, et al. Transforming growth factor-beta inhibits interferon-gamma secretion by lymphokine-activated killer cells stimulated with tumor cells. Neurol Med Chir (Tokyo) 1996;36:789-795.
254. Bellone G, Aste-Amezaga M, Trinchieri G, Rodeck U. Regulation of NK cell functions by TGF-beta 1. J Immunol 1995;155:1066-1073.
255. Kehrl JH, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-1050.
256. Ruegemer JJ, et al. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression. J Immunol 1990;144:1767-1776.
257. Nelson BJ, Ralph P, Green SJ, Nacy CA. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J Immunol 1991;146:1849-1857.
258. Khalil N. Post translational activation of latent transforming growth factor beta (L-TGF-beta): clinical implications. Histol Histopathol 2001;16:541-551.
259. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23:225-274.
260. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000;290:84-89.
261. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
262. McMahon CW, Raulet DH. Expression and function of NK cell receptors in CD8+ T cells. Curr Opin Immunol 2001;13:465-470.
263. Colonna M, Nakajima H, Navarro F, Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 1999;66:375-381.
264. Fanger NA, Borges L, Cosman D. The leukocyte immunoglobulin-like receptors (LIRs): a new family of immune regulators. J Leukoc Biol 1999;66:231-236.
265. Oberg L, Eriksson M, Fahlen L, Sentman CL. Expression of Ly49A on T cells alters the threshold for T cell responses. Eur J Immunol 2000;30:2849-2856.
266. Lanier LL. On guard - activating NK cell receptors. Nat Immunol 2001;2:23-27.
267. Smith HR, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002;99:8826-8831.
268. Voigt V, et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA 2003;100:13483-13488.
269. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996;93:12445-12450.
270. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 1999;96:6879-6884.
271. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3:781-790.
272. Carbone E, et al. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med 1997;185:2053-2060.
273. Chambers BJ, Salcedo M, Ljunggren HG. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 1996;5:311-317.
274. Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4(CD158d) in resting NK cells. J Immunol 2001;167:1877-1881.
275. van der Meer A, et al. Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. Mol Hum Reprod 2004;10:189-195.
276. Greenwood JD, Minhas K, di Santo JP, Makita M, Kiso Y, Croy BA. Ultrastructural studies of implantation sites from mice deficient in uterine natural killer cells. Placenta 2000;21:693-702.
277. Ashkar AA, et al. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol 2003;171:2937-2944.
278. Hunt JS, Miller L, Vassmer D, Croy BA. Expression of the inducible nitric oxide synthase gene in mouse uterine leukocytes and potential relationships with uterine function during pregnancy. Biol Reprod 1997;57:827-836.
279. Hornung V, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002;168:4531-4537.
280. Chalifour A, Roger J, Lemieux S, Duplay P. Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation. Immunology 2003;109:58-67.
281. Sivori S, Parolini S, Marcenaro E, Millo R, Bottino C, Moretta A. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum Immunol 2000;61:1055-1058.
282. Krieg AM. Now I know my CpGs. Trends Microbiol 2001;9:249-252.
283. Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 2002;4:1545-1558.
284. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005;5:112-124.
285. Tasca S, et al. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. Aids 2003;17:2291-2298.
286. Peruzzi M, Azzari C, Rossi ME, De Martino M, Vierucci A. Inhibition of natural killer cell cytotoxicity and interferon gamma production by the envelope protein of HIV and prevention by vasoactive intestinal peptide. AIDS Res Hum Retroviruses 2000;16:1067-1073.
287. Downey GP, Doherty DE, Schwab B III, Elson EL, Henson PM, Worthen GS. Retention of leukocytes in capillaries: role of cell size and deformability. J Appl Physiol 1990;69:1767-1778.
288. Phillips ML, et al. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J Clin Invest 1995;96:2898-2906.
289. Nathan C. Points of control in inflammation. Nature 2002;420:846-852.
290. Lawrence MB, Springer TA. Neutrophils roll on E-selectin. J Immunol 1993;151:6338-6346.
291. Kolanus W, et al. Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 1996;86:233-242.
292. Huber AR, Kunkel SL, Todd RF III, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991;254:99-102.
293. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178:449-460.
294. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003;5:1317-1327.
295. Lomas DA, et al. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J Biol Chem 1995;270:23437-23443.
296. Gale LM, McColl SR. Chemokines: extracellular messengers for all occasions? Bioessays 1999;21:17-28.
297. Godaly G, et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 2001;69:899-906.
298. Heit B, Tavener S, Raharjo E, Kubes P. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J Cell Biol 2002;159:91-102.
299. Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 2003;102:2660-2669.
300. Brown EJ. The role of extracellular matrix proteins in the control of phagocytosis. J Leukoc Biol 1986;39:579-591.
301. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987;80:1550-1560.
302. Faurschou M, Sorensen OE, Johnsen AH, Askaa J, Borregaard N. Defensin-rich granules of human neutrophils: characterization of secretory properties. Biochim Biophys Acta 2002;1591:29-35.
303. Degousee N, et al. Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J Biol Chem 2002;277:5061-5073.
304. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995;16:21-26.
305. Klein JB, et al. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J Immunol 2000;164:4286-4291.
306. Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N. The Transcriptional Activation Program of Human Neutrophils in Skin Lesions Supports Their Important Role in Wound Healing. J Immunol 2004;172:7684-7693.
307. Gasperini S, et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 1999;162:4928-4937.
308. Bennouna S, Bliss SK, Curiel TJ, Denkers EY. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J Immunol 2003;171:6052-6058.
309. Kunz G, Beil D, Deiniger H, Einspanier A, Mall G, Leyendecker G. The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract. Adv Exp Med Biol 1997;424:267-277.
310. Goverde AJ, Schats R, van Berlo PJ, Claessen FA. An unexpected guest in follicular fluid. Hum Reprod 1996;11:531-532.
311. Patton DL, Thwin SS, Meier A, Hooton TM, Stapleton AE, Eschenbach DA. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol 2000;183:967-973.
312. Sonoda Y, et al. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine (s). J Immunol 1998;160:6159-6165.
313. Cauci S, et al. Interrelationships of interleukin-8 with interleukin-1 beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 2003;9:53-58.
314. Kidney JC, Proud D. Neutrophil transmigration across human airway epithelial monolayers: mechanisms and dependence on electrical resistance. Am J Respir Cell Mol Biol 2000;23:389-395.
315. Matthijs A, Engel B, Woelders H. Neutrophil recruitment and phagocytosis of boar spermatozoa after artificial insemination of sows, and the effects of inseminate volume, sperm dose and specific additives in the extender. Reproduction 2003;125:357-367.
316. Phillips DM, Mahler S. Leukocyte emigration and migration in the vagina following mating in the rabbit. Anat Rec 1977;189:45-59.
317. Pandya IJ, Cohen J. Leukocyte reaction of the human cervix to spermatozoa. Fertil Steril 1985;43:412-421.
318. Denison FC, Grant VE, Calder AA, Kelly RW. Seminal plasma components stimulate interleukin-8 and interleukin-10 release. Mol Hum Reprod 1999;5:220-226.
319. Fidel PL Jr, et al. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 2004;72:2939-2946.
320. Thompson LA, Tomlinson MJ, Barratt CL, Bolton AE, Cooke ID. Positive immunoselection - a method of isolating leukocytes from leukocytic reacted human cervical mucus samples. Am J Reprod Immunol 1991;26:58-61.
321. Thompson LA, Barratt CL, Bolton AE, Cooke ID. The leukocytic reaction of the human uterine cervix. Am J Reprod Immunol 1992;28:85-89.
322. Bohmer JT, Schemmer G, Harrison FN Jr, Kreft W, Elliot M. Cervical wet mount as a negative predictor for gonococci- and Chlamydia trachomatis-induced cervicitis in a gravid population. Am J Obstet Gynecol 1999;181:283-287.
323. Kelly RW. Inflammatory mediators and cervical ripening. J Reprod Immunol 2002;57:217-224.
324. Barclay CG, Brennand JE, Kelly RW, Calder AA. Interleukin-8 production by the human cervix. Am J Obstet Gynecol 1993;169:625-632.
325. Watari M, Watari H, Fujimoto T, et al. Lipopolysaccharide induces interleukin-8 production by human cervical smooth muscle cells. J Soc Gynecol Invest 2003;10:110-117.
326. Critchley HO, Kelly RW, Kooy J. Perivascular location of a chemokine interleukin-8 in human endometrium: a preliminary report. Hum Reprod 1994;9:1406-1409.
327. Arici A, Seli E, Senturk LM, Gutierrez LS, Oral E, Taylor HS. Interleukin-8 in the human endometrium. J Clin Endocrinol Metab 1998;83:1783-1787.
328. Kelly RW, Illingworth P, Baldie G, Leask R, Brouwer S, Calder AA. Progesterone control of interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition. Hum Reprod 1994;9:253-258.
329. Critchley HO, et al. Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab 1999;84:240-248.
330. Salamonsen LA, Woolley DE. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 1999;44:1-27.
331. Paul TR, Knight ST, Raulston JE, Wyrick PB. Delivery of azithromycin to Chlamydia trachomatis-infected polarized human endometrial epithelial cells by polymorphonuclear leucocytes. J Antimicrob Chemother 1997;39:623-630.
332. Salamonsen LA, Lathbury LJ. Endometrial leukocytes and menstruation. Hum Reprod Update 2000;6:16-27.
333. Zhang J, Hampton AL, Nie G, Salamonsen LA. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol Reprod 2000;62:85-94.
334. Spitznagel JK, et al. Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest 1974;30:774-785.
335. Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/pro-bactenecin- like protein of human neutrophil specific granules. FEBS Lett 1995;368:173-176.
336. King AE, Critchley HO, Sallenave JM, Kelly RW. Elafin in human endometrium: an antiprotease and antimicrobial molecule expressed during menstruation. J Clin Endocrinol Metab 2003;88:4426-4431.
337. Chegini N, Tang XM, Dou Q. The expression, activity and regulation of granulocyte macrophage-colony stimulating factor in human endometrial epithelial and stromal cells. Mol Hum Reprod 1999;5:459-466.
338. Yeaman GR, Collins JE, Currie JK, Guyre PM, Wira CR, Fanger MW. IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. J Immunol 1998;160:5145-5153.
339. Appelberg R. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections. Immunobiology 1994;191:520-525.
340. Wollen AL, Sandvei R, Mork S, Marandon JL, Matre R. In situ characterization of leukocytes in the fallopian tube in women with or without an intrauterine contraceptive device. Acta Obstet Gynecol Scand 1994;73:103-112.
341. Hunt JL, Lynn AA. Histologic features of surgically removed fallopian tubes. Arch Pathol Lab Med 2002;126:951-955.
342. Palter SF, Mulayim N, Senturk L, Arici A. Interleukin-8 in the human fallopian tube. J Clin Endocrinol Metab 2001;86:2660-2667.
343. Johnson RM. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect Immun 2004;72:3951-3960.
344. Brannstrom M, Pascoe V, Norman RJ, McClure N. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil Steril 1994;61:488-495.
345. Herriot DM, Warnes GM, Kerin JF. Pregnancy-related chemotactic activity of human follicular fluid. Fertil Steril 1986;45:196-201.
346. Runesson E, Ivarsson K, Janson PO, Brannstrom M. Gonadotropin- and cytokine-regulated expression of the chemokine interleukin 8 in the human preovulatory follicle of the menstrual cycle. J Clin Endocrinol Metab 2000;85:4387-4395.
347. Brannstrom M, Enskog A. Leukocyte networks and ovulation. J Reprod Immunol 2002;57:47-60.
348. Brannstrom M, Bonello N, Norman RJ, Robertson SA. Reduction of ovulation rate in the rat by administration of a neutrophil-depleting monoclonal antibody. J Reprod Immunol 1995;29:265-270.
349. Liu L, Mul FP, Lutter R, Roos D, Knol EF. Transmigration of human neutrophils across airway epithelial cell monolayers is preferentially in the physiologic basolateral-to-apical direction. Am J Respir Cell Mol Biol 1996;15:771-780.
350. Zhao Y, Chegini N. The expression of granulocyte macrophage-colony stimulating factor (GM-CSF) and receptors in human endometrium. Am J Reprod Immunol 1999;42:303-311.
351. Luu NT, Rainger GE, Buckley CD, Nash GB. CD31 regulates direction and rate of neutrophil migration over and under endothelial cells. J Vasc Res 2003;40:467-479.
352. Dangerfield J, Larbi KY, Huang MT, Dewar A, Nourshargh S. PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta1 on transmigrated neutrophils in vivo and plays a functional role in the ability of alpha6 integrins to mediate leukocyte migration through the perivascular basement membrane. J Exp Med 2002;196:1201-1211.
353. Kolotila MP, Diamond RD. Stimulation of neutrophil actin polymerization and degranulation by opsonized and unopsonized Candida albicans hyphae and zymosan. Infect Immun 1988;56:2016-2022.
354. Cui Y, et al. Cytosolic inactivation of translocated neutrophil plasma membrane protein tyrosine phosphatase. Blood 1996;87:341-349.
355. Zhao Y, Chegini N. Human fallopian tube expresses granulocyte-macrophage colony stimulating factor (GM-CSF) and GM-CSF alpha and beta receptors and contain immunoreactive GM-CSF protein. J Clin Endocrinol Metab 1994;79:662-665.
356. Stocks S, Kerr M. Stimulation of neutrophil adhesion by antibodies recognizing CD15 (Le (X)) and CD15-expressing carcinoembryonic antigen-related glycoprotein NCA. Biochem J 1992;288:23-27.
357. Albrechtsen M, Kerr MA. Characterization of human neutrophil glycoproteins expressing the CD15 differentiation antigen (3-fucosyl-N- acetyllactosamine). Br J Haematol 1989;72:312-320.
358. Lund-Johansen F, et al. Activation of human phagocytes through carbohydrate antigens (CD15, sialyl-CD15, CDw17, and CDw65). J Immunol 1992;148:3221-3229.
359. Bates DO, Lodwick D, Williams B. Vascular endothelial growth factor and microvascular permeability. Microcirculation 1999;6:83-96.
360. Le Page C, Genin P, Baines MG, Hiscott J. Interferon activation and innate immunity. Rev Immunogenet 2000;2:374-386.